KN046 in Subjects With Advanced Squamous Non-small Cell Lung Cancer

NCT04474119 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

482

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Non-small-cell Lung Cancer

Interventions

DRUG: KN046
DRUG: KN046 placebo

Sponsor

Jiangsu Alphamab Biopharmaceuticals Co., Ltd